Möchten Sie immer auf dem neuesten Stand bleiben?

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...

NEW TAIPEI CITY, Taiwan, March 20, 2026 (GLOBE NEWSWIRE) -- Brook Gaming, the global leader in cross-platform controller solutions, today announced the global launch of the Wingman P5. This...

Hyderabad, March 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence’s latest report, the global DNA sequencing market is witnessing strong growth, driven by advancements in genomic...

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became...

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the...

Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong interest from investigators and patients; topline data...

New York City, NY, March 18, 2026 (GLOBE NEWSWIRE) -- Memo Genesis is now launching in global markets, with initial availability across the United States and Canada. As interest in cognitive...

COMPLETION OF SOCIETE GENERALE’S EUR 1,462 MILLION SHARE BUY-BACK PROGRAMME FOR CANCELLATION PURPOSE Regulated Information Paris, 18 March 2026 Societe Generale announces the completion of its...

Azalea highlights Nature publication demonstrating in vivo CAR T engineering through site-specific genomic integration with durable anti-tumor activity.

Oral presentation of Ph 1a clinical data highlights potential best-in-class drug profile in heavily pretreated patients with PI3Ka-mutant metastatic breast cancer and other solid tumors Overall,...